Choosing an expression system by what the protein needs rather than by what the laboratory owns: why baculovirus protein expression in insect cells handles large, multi domain and membrane proteins that bacteria will not fold, what mammalian expression vectors give in human like modification and cost in time and yield, where chemically competent e coli and a dh5 alpha strain sit as cloning hosts rather than expression ones, why an expression strain is chosen for protease deficiency and repression instead, what a reporter gene assay adds as a functional readout of an expression construct, and what has to be measured before a system is declared to work
Expression systems are chosen by what the protein cannot do without: disulphide bonds, glycosylation, membrane insertion or simply size. Bacteria are fastest and least capable; insect cells handle complexity at moderate cost; mammalian cells give human like processing slowly and expensively.
- the biosafety manual that decides handling for biological material
- BMBL
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
- the labelling clause behind research use only on a reagent
- 809.10(c)
The figures in this panel are regulation and standard identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply a price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Choosing the route
- List the modifications the protein requires. Disulphide bonding, glycosylation, phosphorylation and membrane insertion each rule systems in or out. That list, written first, selects the host without further debate.
- Separate cloning hosts from expression hosts. A high efficiency cloning strain is optimised for uptake and plasmid stability, not for expressing protein without degrading it. Using one to express is a common quiet failure.
- Budget the insect system's timeline honestly. Generating and amplifying virus adds weeks before any protein appears, and titre has to be tracked. The capability is real and it is not fast.
- Choose the mammalian route for human like product. Transient expression gives milligrams in weeks; stable lines give more, later. Both cost considerably more per milligram than the alternatives and are the only route for some proteins.
- Use a reporter to validate the construct. A reporter in the same vector confirms transcription, translation and delivery independently of whether your protein folds. It separates construct problems from protein problems.
- Characterise before declaring success. Yield, purity, aggregation state and activity. A system that gives high yield of misfolded protein has not worked, and only the activity measurement reveals it.
Yield is not the objective
A system that produces large amounts of insoluble or misfolded protein has not solved the problem. The measurement that matters is active, correctly folded protein per unit of effort.
Include an activity assay in the screen from the start, not after purification. It changes which conditions look best.
Screen in parallel, not in series
Host, construct boundaries, tag position and temperature interact, and testing them one at a time takes a quarter. Small parallel screens answer in a week.
It is the highest return activity in the whole workflow and the one most often skipped under time pressure.
Common questions
- When should I move beyond bacterial expression?
- When the protein needs glycosylation, complex disulphide bonding, membrane insertion or is large and multi domain. Those are folding requirements that induction conditions cannot fix.
- Why not use a cloning strain to express?
- Because it lacks protease deficiency and tight repression, so the protein is degraded or the construct is lost. Expression strains exist for exactly those properties.
- How long does an insect cell campaign take?
- Weeks before protein appears, because virus has to be generated, amplified and titred first. It is a capable system and it should not be chosen when speed is the constraint.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/baculovirus-protein-expression/.